When Treating Cancer, Please Don't Forget Hepatitis B

被引：3
作者：
King, Lindsay Y. [2 ,3 ]
Chung, Raymond T. [1 ,3 ]
机构：
[1] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA
[2] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
来源：
ONCOLOGIST | 2010年 / 15卷 / 08期
关键词：
Hepatitis B; Reactivation; Chemotherapy; HBV; VIRUS REACTIVATION; CYTOTOXIC CHEMOTHERAPY; HBV REACTIVATION; RISK-FACTORS; LAMIVUDINE; THERAPY; PREVENTION; MANAGEMENT; INFECTION; CARRIERS;
D O I：
10.1634/theoncologist.2009-0282
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：826 / 829
页数：4
相关论文
共 25 条
  • [1] Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours
    Alexopoulos, CG
    Vaslamatzis, W
    Hatzidimitriou, G
    [J]. BRITISH JOURNAL OF CANCER, 1999, 81 (01) : 69 - 74
  • [2] Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration
    Dai, MS
    Wu, PF
    Shyu, RY
    Lu, JJ
    Chao, TY
    [J]. LIVER INTERNATIONAL, 2004, 24 (06) : 540 - 546
  • [3] Drug therapy - Hepatitis B virus infection
    Dienstag, Jules L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (14) : 1486 - 1500
  • [4] REACTIVATION OF CHRONIC HEPATITIS B-VIRUS INFECTION BY CANCER-CHEMOTHERAPY
    HOOFNAGLE, JH
    DUSHEIKO, GM
    SCHAFER, DF
    JONES, EA
    MICETICH, KC
    YOUNG, RC
    COSTA, J
    [J]. ANNALS OF INTERNAL MEDICINE, 1982, 96 (04) : 447 - 449
  • [5] Hsu CH, 2004, ANTICANCER RES, V24, P3035
  • [6] A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
    Hsu, Chiun
    Hsiung, Chao A.
    Su, Lh-Jen
    Hwang, Wei-Shou
    Wang, Ming-Chung
    Lin, Sheng-Fung
    Lin, Tseng-Hsi
    Hsiao, Hui-Hua
    Young, Ji-Hsiung
    Chang, Ming-Chih
    Liao, Yu-Min
    Li, Chi-Cheng
    Wu, Hung-Bo
    Tien, Hwei-Fang
    Chao, Tsu-Yi
    Hu, Tsang-Wu
    Cheng, Ann-Lii
    Chen, Pei-Jer
    [J]. HEPATOLOGY, 2008, 47 (03) : 844 - 853
  • [7] Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis
    Katz, L. H.
    Fraser, A.
    Gafter-Gvili, A.
    Leibovici, L.
    Tur-Kaspa, R.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2008, 15 (02) : 89 - 102
  • [8] Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy
    Lau, GKK
    Yiu, HHY
    Fong, DYT
    Cheng, HC
    Au, WY
    Lai, LSF
    Cheung, M
    Zhang, HY
    Lie, A
    Ngan, R
    Liang, R
    [J]. GASTROENTEROLOGY, 2003, 125 (06) : 1742 - 1749
  • [9] Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation
    Lau, GKK
    He, ML
    Fong, DYT
    Bartholomeusz, A
    Au, WY
    Lie, AKW
    Locarnini, S
    Liang, R
    [J]. HEPATOLOGY, 2002, 36 (03) : 702 - 709
  • [10] Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
    Lavanchy, D
    [J]. JOURNAL OF VIRAL HEPATITIS, 2004, 11 (02) : 97 - 107
123